1-4 of 4
Jill Tate
Close
Sort by
Journal Articles

Clinical Comparison of a New Serum Free Light Chain (FLC) Assay Based on the Seralite Monoclonal Anti-FLC Antibodies with the Freelite and N-Latex FLC Assays in the Diagnosis of AL Amyloidosis

Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Carel Pretorius, MBBS, Mark T Drayson, MD PhD, Jill Tate
Journal: Blood
Blood (2017) 130 (Supplement 1): 4345.
https://doi.org/10.1182/blood.V130.Suppl_1.4345.4345
Published: 2017
Journal Articles

Clinical Comparison of the Freelite and N-Latex Serum Free Light Chain (FLC) Assays in the Diagnosis and Monitoring of AL Amyloidosis

Sally Mapp, MBBS, FRACP, FRCPA, Jill Tate, BSc, MSc, FFSc, Carel Pretorius, MBChB, FCPathChem(SA), Peter Mollee, MBBS, FRCPA, FRACP, MMSc
Journal: Blood
Blood (2012) 120 (21): 4991.
https://doi.org/10.1182/blood.V120.21.4991.4991
Published: 2012
Journal Articles

A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,

Peter Mollee, MBBS, FRCPA, FRACP, MMSc, Campbell Tiley, MBBS, FRACP, FRCPA, Ilona Cunningham, John Moore, Miles Prince, MD, FRACP, FRCPA, Paul Cannell, MBBS, FRCPA, FRACP, Steve Gibbons, FRCPA, FRACP, MB, CHB, Jill Tate, BSc, MSc, FFSc, Sanjoy Paul, PhD, MSc, Devinder S Gill, MD
Journal: Blood
Blood (2011) 118 (21): 3973.
https://doi.org/10.1182/blood.V118.21.3973.3973
Published: 2011
Journal Articles

Falsely Low Serum Free Light Chain Concentration in Patients with Monoclonal Light Chain Diseases.

Peter Mollee, MBBS, MMedSc, Jill Tate, BSc, Goce Dimeski, BSc, Devinder Gill, MBBS
Journal: Blood
Blood (2005) 106 (11): 5077.
https://doi.org/10.1182/blood.V106.11.5077.5077
Published: 2005